Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 70, 2006 - Issue 9
Journal homepage
231
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Endogenous Prostaglandins E2 and F2α Serve as an Anti-Apoptotic Factor against Apoptosis Induced by Tumor Necrosis Factor-α in Mouse 3T3-L1 Preadipocytes

Kohji NISHIMURADepartment of Molecular and Functional Genomics, Center for Integrated Research in Science, Shimane University
,
Tsutomu SETOYAMADepartment of Life Science and Biotechnology, Shimane University
,
Hirofumi TSUMAGARIDepartment of Life Science and Biotechnology, Shimane University
,
Nana MIYATADepartment of Life Science and Biotechnology, Shimane University
,
Yoko HATANODepartment of Life Science and Biotechnology, Shimane University
,
Li XUDepartment of Life Science and Biotechnology, Shimane University
,
Mitsuo JISAKADepartment of Life Science and Biotechnology, Shimane University
,
Tsutomu NAGAYADepartment of Life Science and Biotechnology, Shimane University
&
Kazushige YOKOTADepartment of Life Science and Biotechnology, Shimane University
 show all
Pages 2145-2153 | Received 28 Feb 2006, Accepted 26 Apr 2006, Published online: 22 May 2014

  • 1) Saltiel, A. R., and Kahn, C. R., Insulin signaling and the regulation of glucose and lipid metabolism. Nature, 414, 799–806 (2001).
  • 2) Despres, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., and Bouchard, C., Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis, 10, 497–511 (1990).
  • 3) Flier, J. S., The adipocyte: storage depot or node on the energy information superhighway? Cell, 80, 15–18 (1995).
  • 4) Mandrup, S., and Lane, M. D., Regulating adipogenesis. J. Biol. Chem., 272, 5367–5370 (1997).
  • 5) Tontonoz, P., Hu, E., and Spiegelman, B. M., Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell, 79, 1147–1156 (1994).
  • 6) Trayhurn, P., and Beattie, J. H., Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc., 60, 329–339 (2001).
  • 7) Rink, L., and Kirchner, H., Recent progress in the tumor necrosis factor-α field. Int. Arch. Allergy Immunol., 111, 199–209 (1996).
  • 8) Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., and Simsolo, R. B., The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest., 95, 2111–2119 (1995).
  • 9) Sethi, J. K., and Hotamisligil, G. S., The role of TNFα in adipocyte metabolis. Semin. Cell Dev. Biol., 10, 19–29 (1999).
  • 10) Prins, J. B., Niesler, C. U., Winterford, C. M., Bright, N. A., Siddle, K., O’Rahilly, S., Walker, N. I., and Cameron, D. P., Tumor necrosis factor-α induces apoptosis of human adipose cells. Diabetes, 46, 1939–1944 (1997).
  • 11) Needleman, P., Turk, J., Jakschik, B. A., Morrison, A. R., and Lefkowith, J. B., Arachidonic acid metabolism. Ann. Rev. Biochem., 55, 69–102 (1986).
  • 12) Yamamoto, S., Mammalian lipoxygenases: molecular structures and functions. Biochim. Biophys. Acta, 1128, 117–131 (1992).
  • 13) Bronstein, J. C., and Bull, A. W., The correlation between 13-hydroxyoctadecadienoate dehydrogenase (13-HODE dehydrogenase) and intestinal cell differentiation. Prostaglandins, 46, 387–395 (1993).
  • 14) Eberhart, C. E., and DuBois, R. N., Eicosanoids and the gastrointestinal tract. Gastroenterology, 109, 285–301 (1995).
  • 15) Marnett, L., Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575–5589 (1992).
  • 16) Tsujii, M., and DuBois, R. N., Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493–501 (1995).
  • 17) Brown, D. B., Warner, G. L., Alés-Martínez, J. E., Scott, D. W., and Phipps, R. P., Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes. Clin. Immun. Immunopath., 63, 221–229 (1992).
  • 18) Lu, X., Xie, W., Reed, D., Bradshaw, W. S., and Simmons, D. L., Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 92, 7961–7965 (1995).
  • 19) Anderson, K. M., Wiederhold, M., and Ondrey, F., Participation of lipoxygenase products in lymphohematopoietic and other cell proliferation and differentiation. In “Prostaglandin Inhibitors in Tumor Immunology and Immunotherapy,” eds. Harris, J. E., Braun, D. P., and Anderson, K. M., CRC Press, Boca Raton, pp. 41–72 (1994).
  • 20) Clay, C. E., Namen, A. M., Atsumi, G., Willingham, M. C., High, K. P., Kute, T. E., Trimboli, A. J., Fonteh, A. N., Dawson, P. A., and Chilton, F. H., Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis, 20, 1905–1911 (1999).
  • 21) Piazza, G. A., Rahm, A. L., Krutzsch, M., Sperl, G., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., Pamukcu, R., and Ahnen, D. J., Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55, 3110–3116 (1995).
  • 22) Avis, I. M., Jett, M., Boyle, T., Vos, M. D., Moody, T., Treston, A. M., Martínez, A., and Mulshine, J. L., Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J. Clin. Invest., 97, 806–813 (1996).
  • 23) O’Donnell, V. B., Spycher, S., and Azzi, A., Involvement of oxidants and oxidant-generating enzyme(s) in tumor-necrosis-factor-α-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem. J., 310, 133–141 (1995).
  • 24) Chang, D. J., Ringold, G. M., and Heller, R. A., Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolites of arachidonic acid. Biochem. Biophys. Res. Commun., 188, 538–546 (1992).
  • 25) Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M., 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell, 83, 803–812 (1995).
  • 26) Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M., A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell, 83, 813–819 (1995).
  • 27) Meade, E. A., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M., Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J. Biol. Chem., 274, 8328–8334 (1999).
  • 28) Fain, J. N., Ballou, L. R., and Bahouth, S. W., Obesity is induced in mice heterozygous for cyclooxygenase-2. Prostaglandins Other Lipid Mediat., 65, 199–209 (2001).
  • 29) Green, H., and Kehinde, O., An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell, 5, 19–27 (1975).
  • 30) Hyman, B. T., Stoll, L. L., and Spector, A. A., Prostaglandin production by 3T3-L1 cells in culture. Biochim. Biophys. Acta, 713, 375–385 (1982).
  • 31) Casimir, D. A., Miller, C. W., and Ntambi, J. M., Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation, 60, 203–210 (1996).
  • 32) Reginato, M. J., Krakow, S. L., Bailey, S. T., and Lazar, M. A., Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. J. Biol. Chem., 273, 1855–1858 (1998).
  • 33) Nishimura, K., Hatano, Y., Setoyama, T., Tsumagari, H., Miyashita, K., Lu, S., Jisaka, M., Nagaya, T., and Yokota, K., Control of life cycle of mouse adipogenic 3T3-L1 cells by dietary lipids and metabolic factors. Appl. Biochem. Biotechnol., 118, 97–114 (2004).
  • 34) Nishimura, K., Tsumagari, H., Morioka, A., Yamauchi, Y., Jisaka, M., Nagaya, T., and Yokota, K., Regulation of apoptosis through the arachidonate cascade in mammalian cells. Appl. Biochem. Biotechnol., 102–103, 239–250 (2002).
  • 35) Yokota, K., Takeuchi, J., Jisaka, M., and Takinami, K., Activation mechanism of phospholipase D involved in the generation of lipid mediators in cultured Madin-Darby canine kidney cells. Biosci. Biotechnol. Biochem., 59, 1291–1299 (1995).
  • 36) Yokota, K., Morishita, T., Nagaya, T., Jisaka, M., and Takinami, K., Modification of cultured Madin-Darby canine kidney cells with dietary unsaturated fatty acids and regulation of arachidonate cascade reaction. Biosci. Biotechnol. Biochem., 60, 1096–1103 (1996).
  • 37) Chomczynski, P., and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156–159 (1987).
  • 38) Nishimura, K., Tsumagari, H., Setoyama, T., Morioka, A., Lu, S., Jisaka, M., Nagaya, T., and Yokota, K., Prostaglandin F2α is protective for apoptosis stimulated synergistically with 12-O-tetradecanoyl phorbol-β-acetate and nordihydroguaiaretic acid in Madin-Darby canine kidney cells. Biochim. Biophys. Acta, 1682, 102–111 (2004).
  • 39) Lu, S., Nishimura, K., Hossain, M. A., Jisaka, M., Nagaya, T., and Yokota, K., Regulation and role of arachidonate cascade during changes in life cycle of adipocytes. Appl. Biochem. Biotechnol., 118, 133–153 (2004).
  • 40) Magun, R., Boone, D. L., Tsang, B. K., and Sorisky, A., The effect of adipocyte differentiation on the capacity of 3T3-L1 cells to undergo apoptosis in response to growth factor deprivation. Int. J. Obes. Relat. Metab. Disord., 22, 567–571 (1998).
  • 41) Garg, A. K., and Aggarwal, B. B., Reactive oxygen intermediates in TNF signalin. Mol. Immunol., 39, 509–517 (2002).
  • 42) Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., and Ichijo, H., ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep., 2, 222–228 (2001).
  • 43) Su, X., Mancuso, D. J., Bickel, P. E., Jenkins, C. M., and Gross, R. W., Small interfering RNA knockdown of calcium-independent phospholipases A2 β or γ inhibits the hormone-induced differentiation of 3T3-L1 preadipocytes. J. Biol. Chem., 279, 21740–21748 (2004).
  • 44) Schoonjans, K., Staels, B., and Auwerx, J., The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta, 1302, 93–109 (1996).
  • 45) Murphy, G. J., and Holder, J. C., PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. Sci., 21, 469–474 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.